Impact of Gap Junctional Intercellular Communication on MLO-Y4 Sclerostin and Soluble Factor Expression

Overview

Journal Ann Biomed Eng

Specialty Biomedical Engineering

Date 2015 Jul 9

PMID 26154422

Citations 5

Authors

S L York

P Sethu

M M Saunders

Affiliations

Soon will be listed here.

Abstract

Bone remodeling is a continual process in which old bone is resorbed by osteoclasts and new bone is formed by osteoblasts, providing a mechanism for bones' ability to adapt to changes in its mechanical environment. While the role of osteoblasts and osteoclasts in bone remodeling is well understood, the cellular regulation of bone remodeling is unclear. One theory is that osteocytes, found within bone, play an important role in controlling the bone remodeling response. Osteocytes possess gap junctions, narrow channels that extend between nearby cells and allow communication between cells via the transfer of small molecules and ions. This work investigated the potential role of gap junctional intercellular communication in bone remodeling by exposing osteocyte-like MLO-Y4 cells to mechanical strains and quantifying the expression of soluble factors, including sclerostin, a protein closely associated with bone remodeling. The soluble factors and sclerostin expression were further examined after inhibiting gap junctional intercellular communication to study the impact of the communication. At supraphysiologic strains, the inhibition of gap junctional intercellular communication led to increases in sclerostin expression relative to cells in which communication was present, indicating that the communication may play a significant role in regulating bone remodeling.

Citing Articles

Tracing Cellular Senescence in Bone: Time-Dependent Changes in Osteocyte Cytoskeleton Mechanics and Morphology.

Tilton M, Liao J, Kim C, Shaygani H, Potes M, Cordova D bioRxiv. 2025; .

PMID: 39896626 PMC: 11785097. DOI: 10.1101/2024.09.28.615585.

model to study confined osteocyte networks exposed to flow-induced mechanical stimuli.

Zhang K, Ogando C, Filip A, Zhang T, Horton J, Soman P Biomed Mater. 2022; 17(6).

PMID: 36384043 PMC: 10642715. DOI: 10.1088/1748-605X/aca37c.

Osteocytic cells exposed to titanium particles increase sclerostin expression and inhibit osteoblastic cell differentiation mostly via direct cell-to-cell contact.

Chai H, Zhang Z, Fang J, She C, Geng D, Xu W J Cell Mol Med. 2022; 26(15):4371-4385.

PMID: 35762300 PMC: 9345295. DOI: 10.1111/jcmm.17460.

Effects of BDNF and PEC Nanoparticles on Osteocytes.

Loy T, Vehlow D, Kauschke V, Muller M, Heiss C, Lips K Molecules. 2020; 25(18).

PMID: 32927875 PMC: 7570603. DOI: 10.3390/molecules25184151.

Connexin43 enhances Wnt and PGE2-dependent activation of β-catenin in osteoblasts.

Gupta A, Chatree S, Buo A, Moorer M, Stains J Pflugers Arch. 2019; 471(9):1235-1243.

PMID: 31240382 PMC: 6711805. DOI: 10.1007/s00424-019-02295-y.

References

Brown T . Techniques for mechanical stimulation of cells in vitro: a review. J Biomech. 1999; 33(1):3-14. DOI: 10.1016/s0021-9290(99)00177-3. View

Donahue H . Gap junctions and biophysical regulation of bone cell differentiation. Bone. 2000; 26(5):417-22. DOI: 10.1016/S8756-3282(00)00245-3. View

Haapasalo H, Kontulainen S, Sievanen H, Kannus P, Jarvinen M, Vuori I . Exercise-induced bone gain is due to enlargement in bone size without a change in volumetric bone density: a peripheral quantitative computed tomography study of the upper arms of male tennis players. Bone. 2000; 27(3):351-7. DOI: 10.1016/s8756-3282(00)00331-8. View

Winkler D, Sutherland M, Geoghegan J, Yu C, Hayes T, Skonier J . Osteocyte control of bone formation via sclerostin, a novel BMP antagonist. EMBO J. 2003; 22(23):6267-76. PMC: 291840. DOI: 10.1093/emboj/cdg599. View

Martin T, Sims N . Osteoclast-derived activity in the coupling of bone formation to resorption. Trends Mol Med. 2005; 11(2):76-81. DOI: 10.1016/j.molmed.2004.12.004. View

Ortega N, Behonick D, Colnot C, Cooper D, Werb Z . Galectin-3 is a downstream regulator of matrix metalloproteinase-9 function during endochondral bone formation. Mol Biol Cell. 2005; 16(6):3028-39. PMC: 1142445. DOI: 10.1091/mbc.e04-12-1119. View

Orr A, P Helmke B, Blackman B, Schwartz M . Mechanisms of mechanotransduction. Dev Cell. 2006; 10(1):11-20. DOI: 10.1016/j.devcel.2005.12.006. View

Suzuki T, Miyamoto T, Fujita N, Ninomiya K, Iwasaki R, Toyama Y . Osteoblast-specific Angiopoietin 1 overexpression increases bone mass. Biochem Biophys Res Commun. 2007; 362(4):1019-25. DOI: 10.1016/j.bbrc.2007.08.099. View

Robling A, Niziolek P, Baldridge L, Condon K, Allen M, Alam I . Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin. J Biol Chem. 2007; 283(9):5866-75. DOI: 10.1074/jbc.M705092200. View

10.

Pearsall R, Canalis E, Cornwall-Brady M, Underwood K, Haigis B, Ucran J . A soluble activin type IIA receptor induces bone formation and improves skeletal integrity. Proc Natl Acad Sci U S A. 2008; 105(19):7082-7. PMC: 2383948. DOI: 10.1073/pnas.0711263105. View

11.

Lin C, Jiang X, Dai Z, Guo X, Weng T, Wang J . Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt/beta-catenin signaling. J Bone Miner Res. 2009; 24(10):1651-61. DOI: 10.1359/jbmr.090411. View

12.

Baudhuin M, Duplomb L, Teletchea S, Charrier C, Maillasson M, Fouassier M . Factor VIII-von Willebrand factor complex inhibits osteoclastogenesis and controls cell survival. J Biol Chem. 2009; 284(46):31704-13. PMC: 2797241. DOI: 10.1074/jbc.M109.030312. View

13.

Jeong B, Kim H, Bae I, Lee K, Lee K, Oh W . COMP-Ang1, a chimeric form of Angiopoietin 1, enhances BMP2-induced osteoblast differentiation and bone formation. Bone. 2009; 46(2):479-86. DOI: 10.1016/j.bone.2009.09.019. View

14.

Chantry A, Heath D, Mulivor A, Pearsall S, Baudhuin M, Coulton L . Inhibiting activin-A signaling stimulates bone formation and prevents cancer-induced bone destruction in vivo. J Bone Miner Res. 2010; 25(12):2633-46. DOI: 10.1002/jbmr.142. View

15.

Bonewald L . The amazing osteocyte. J Bone Miner Res. 2011; 26(2):229-38. PMC: 3179345. DOI: 10.1002/jbmr.320. View

16.

Becker J, Semler O, Gilissen C, Li Y, Bolz H, Giunta C . Exome sequencing identifies truncating mutations in human SERPINF1 in autosomal-recessive osteogenesis imperfecta. Am J Hum Genet. 2011; 88(3):362-71. PMC: 3059418. DOI: 10.1016/j.ajhg.2011.01.015. View

17.

Homan E, Rauch F, Grafe I, Lietman C, Doll J, Dawson B . Mutations in SERPINF1 cause osteogenesis imperfecta type VI. J Bone Miner Res. 2011; 26(12):2798-803. PMC: 3214246. DOI: 10.1002/jbmr.487. View

18.

Zhang Y, Paul E, Sathyendra V, Davison A, Sharkey N, Bronson S . Enhanced osteoclastic resorption and responsiveness to mechanical load in gap junction deficient bone. PLoS One. 2011; 6(8):e23516. PMC: 3163577. DOI: 10.1371/journal.pone.0023516. View

19.

Nakashima T, Hayashi M, Fukunaga T, Kurata K, Oh-Hora M, Feng J . Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat Med. 2011; 17(10):1231-4. DOI: 10.1038/nm.2452. View

20.

Rosser J, Bonewald L . Studying osteocyte function using the cell lines MLO-Y4 and MLO-A5. Methods Mol Biol. 2011; 816:67-81. DOI: 10.1007/978-1-61779-415-5_6. View